While nearly 400 inferior vena cava (IVC) filter lawsuits are currently pending in the U.S., two class action IVC filter lawsuits have now been filed in Canada as well.
Cook Medical and C.R. Bard, Inc., the manufacturers of the largest share of IVC filters, face allegations that their devices were improperly designed and put patients at risk of serious injury.
As of March 23, 2016, there were 315 lawsuits consolidated for pretrial proceedings against Cook Medical in MDL 2570, and another 93 lawsuits consolidated against Bard in MDL 2641.
The plaintiffs in the Canadian IVC Filter lawsuits allege that their IVC filters broke apart and became lodged inside their bodies.
One of the patients claims that the IVC filter implanted in her body broke apart and one leg pierced her internal jugular vein and the rest migrating into her small intestines.
The woman’s doctors have told her that it is too dangerous to try to remove the device and consequently, she will have to take blood thinners for the rest of her life.
She and her husband filed a $200 million class-action lawsuit against Cook Medical in January 2016, alleging that she was never made aware of the potential risks involved with IVC filters.
IVC filters are implanted in the inferior vena cava to trap blood clots in patients who are at risk of pulmonary embolism but cannot take anticoagulant medications.
Retrievable IVC filters are meant to be temporary, used only until the risk of pulmonary embolism is gone and then removed, but many retrievable IVC filters are left implanted indefinitely, putting patients at an increased risk of device failure.
That risk prompted the FDA to issue a safety alert in 2010, warning that the retrievable IVC filters should be removed as soon as the patient no longer requires intervention to prevent blood clots.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Weis Market Inc., a Mid-Atlantic food retailer based in Sunbury, Pennsylvania, has recalled its 48-ounce containers of Weis Quality Brownie Moose Tracks Ice Cream because the product may contain traces of egg, an allergen not declared on the ingredient statement label, according to the FDA.
Marlex Pharmaceuticals, Inc., of New Castle, Delaware, has announced a voluntary, consumer-level recall of one lot of Digoxin Tablets USP, 0125mg, as well as one lot of Digoxin Tablets USP, 0.25mg, because the labels of both products have been mixed up, according to the FDA.